These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 28654766)

  • 1. Methotrexate-Related Lymphoproliferative Disorder in Patients With Osteonecrosis of the Jaw: A 3-Case Report and Literature Review.
    Furudate K; Satake A; Narita N; Kobayashi W
    J Oral Maxillofac Surg; 2018 Jan; 76(1):97-111. PubMed ID: 28654766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Methotrexate-related Lymphoproliferative Disease Presenting with Severe Osteonecrosis of the Jaw: A Case Report and Literature Review.
    Furukawa S; Oobu K; Moriyama M; Kawano S; Sako S; Hayashida JN; Matsubara R; Ogata KI; Kiyoshima T; Nakamura S
    Intern Med; 2018 Feb; 57(4):575-581. PubMed ID: 29225245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate-related Epstein-Barr virus-associated lymphoproliferative disorder occurring in the gingiva of a patient with rheumatoid arthritis.
    Ishida M; Hodohara K; Yoshii M; Okuno H; Horinouchi A; Nakanishi R; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
    Int J Clin Exp Pathol; 2013; 6(10):2237-41. PubMed ID: 24133604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate-related Epstein-Barr Virus (EBV)-associated lymphoproliferative disorder--so-called "Hodgkin-like lesion"--of the oral cavity in a patient with rheumatoid arthritis.
    Kikuchi K; Miyazaki Y; Tanaka A; Shigematu H; Kojima M; Sakashita H; Kusama K
    Head Neck Pathol; 2010 Dec; 4(4):305-11. PubMed ID: 20676828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate-associated lymphoproliferative disorder in the stomach and duodenum: a case report.
    Toyonaga H; Fukushima M; Shimeno N; Inokuma T
    BMC Gastroenterol; 2019 Apr; 19(1):62. PubMed ID: 31023238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature.
    Ogawa A; Nakagawa T; Kumaki Y; Hosoya T; Oda G; Mori M; Fujioka T; Kubota K; Onishi I; Uetake H
    J Med Case Rep; 2022 Feb; 16(1):49. PubMed ID: 35125110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate-related lymphoproliferative disorder of the stomach in a patient with rheumatoid arthritis: a case of disease regression after methotrexate cessation.
    Ikeda K; Nakamura T; Kinoshita T; Fujiwara M; Uose S; Someda H; Miyoshi T; Io K; Nagai K
    Clin J Gastroenterol; 2016 Feb; 9(1):17-21. PubMed ID: 26733461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate-associated orbital lymphoproliferative disorder in a patient with rheumatoid arthritis: a case report.
    Kobayashi Y; Kimura K; Fujitsu Y; Shinkawa K; Muta H; Sonoda KH
    Jpn J Ophthalmol; 2016 May; 60(3):212-8. PubMed ID: 27018050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cessation of methotrexate and a small intestinal resection provide a good clinical course for a patient with a jejunum perforation induced by a methotrexate-associated lymphoproliferative disorder: a case report.
    Nomura M; Sumiya R; Ono H; Nagai T; Kumazawa K; Shimizu A; Endo D; Aoyanagi N
    World J Surg Oncol; 2021 Jan; 19(1):4. PubMed ID: 33388058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression.
    Ichikawa A; Arakawa F; Kiyasu J; Sato K; Miyoshi H; Niino D; Kimura Y; Takeuchi M; Yoshida M; Ishibashi Y; Nakashima S; Sugita Y; Miura O; Ohshima K
    Eur J Haematol; 2013 Jul; 91(1):20-8. PubMed ID: 23560463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary central nervous system methotrexate associated lymphoproliferative disorders in a patient with rheumatoid arthritis].
    Uchida Y; Hokkoku K; Hatanaka Y; Kikuchi Y; Tashiro H; Sonoo M
    Rinsho Shinkeigaku; 2018 Aug; 58(8):485-491. PubMed ID: 30068810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of multiple hepatic lesions associated with methotrexate-associated lymphoproliferative disorder.
    Matsumoto R; Numata K; Doba N; Hara K; Chuma M; Fukuda H; Nozaki A; Tanaka K; Ishii Y; Maeda S
    J Med Ultrason (2001); 2016 Oct; 43(4):545-51. PubMed ID: 27577564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of positron emission tomography/computed tomography in rheumatoid arthritis patients with methotrexate-associated lymphoproliferative disorders.
    Takanashi S; Nakazato T; Aisa Y; Ito C; Arakaki H; Osada Y; Hirano M; Mori T
    Ann Hematol; 2018 Sep; 97(9):1611-1618. PubMed ID: 29713747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible methotrexate-associated lymphoproliferative disorder resembling advanced gastric cancer in a patient with rheumatoid arthritis.
    Satoh K; Yoshida N; Imaizumi K; Yajima M; Wakui H; Sawada K; Komatsuda A
    Am J Med Sci; 2009 Oct; 338(4):334-5. PubMed ID: 19745701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Three cases of methotrexate-associated lymphoproliferative disorder (MTX-LPD)].
    Ishida Y; Asahi A; Wada T; Kanai N; Kobayashi Y; Moriai S; Kishibe K; Harabuchi Y
    Nihon Jibiinkoka Gakkai Kaiho; 2008 Aug; 111(8):594-8. PubMed ID: 18788425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate-associated lymphoproliferative disorder presenting as extranodal NK/T-cell lymphoma arising in the lungs.
    Tajima S; Takanashi Y; Koda K; Fukayama M
    Pathol Int; 2015 Dec; 65(12):661-5. PubMed ID: 26459854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate-associated lymphoproliferative disorders of the tongue developing in patients with rheumatoid arthritis: a report of 2 cases and a review.
    Hashimoto K; Nagao T; Saito T; Kinoshita H
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):e1-5. PubMed ID: 24927637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.
    Katsuyama T; Sada KE; Yan M; Zeggar S; Hiramatsu S; Miyawaki Y; Ohashi K; Morishita M; Watanabe H; Katsuyama E; Takano-Narazaki M; Toyota-Tatebe N; Sunahori-Watanabe K; Kawabata T; Miyake K; Kiguchi T; Wada J
    Mod Rheumatol; 2017 Sep; 27(5):773-777. PubMed ID: 27846761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate-associated lymphoproliferative disorder with histopathological features of histiocytic necrotizing lymphadenitis.
    Kaito S; Goto M; Iguchi M; Okuno Y; Moriyoshi K; Koyama H
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):141-144. PubMed ID: 33269654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate-associated osteonecrosis of the jaw: A report of two cases.
    Henien M; Carey B; Hullah E; Sproat C; Patel V
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Dec; 124(6):e283-e287. PubMed ID: 29056286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.